Guí a OncoSur de infecc ione s en pac i ente s con tumor de órgano sól ido 62 > BIBLIOGRAFÍA 1. NCCN Clinical Practice Guidelines in Oncology. Prevention and Treatment of Cancer-Related Infections. Version 2, 2020; 2020 June 5. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx 2. Baron Barshak M. Antimicrobial approach to intra-abdominal infections in adults. Uptodate; 2020, June 25. 3. Harbarth S, Uckay I. Are there patients with peritonitis who require empiric therapy for enterococcus? Eur J Clin Microbiol Infect Dis. 2004 Feb;23(2):73-7. 4. Bossi P, Antonuzzo A, Cherny NI, Rosengarten O, Pernot S, Trippa F, et al. Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv126-42. 5. Neemann K, Freifeld A. Clostridium difficile-Associated Diarrhea in the Oncology Patient. J Oncol Pract. 2017 Jan;13(1):25-30. 6. Common Toxicity Criteria, V5.0. Available from: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/TCAE_v5_Quick_Reference_8.5x11.pdf. 7. Andreyev J, Ross P, Donnellan C, Lennan E, Leonard P, Waters C, et al. Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol. 2014 Sep;15(10):e447-60. 8. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. 9. Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, et al. MODIFY I and MODIFY II Investigators. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med. 2017 Jan 26;376(4):305-17.
RkJQdWJsaXNoZXIy OTI4NTYw